Literature DB >> 31209250

Intragenic antagonistic roles of protein and circRNA in tumorigenesis.

Yang Zhang1, Giulia Cheloni1, Riccardo Panella1, Jlenia Guarnerio1,2, Jesse Mae Katon1, Mark Simpson3, Akinobu Matsumoto1, Antonella Papa1, Cristian Loretelli1, Andreas Petri4, Sakari Kauppinen4, Cassandra Garbutt5, Gunnlaugur Petur Nielsen6, Vikram Deshpande6, Mireia Castillo-Martin7, Carlos Cordon-Cardo7, Spentzos Dimitrios5, John G Clohessy1, Mona Batish3,8, Pier Paolo Pandolfi9.   

Abstract

circRNAs arise from back splicing events during mRNA processing, and when deregulated can play an active role in cancer. Here we characterize a new circRNA (circPOK) encoded by the Zbtb7a gene (also kown as POKEMON, LRF) in the context of mesenchymal tumor progression. circPOK functions as a non-coding proto-oncogenic RNA independently and antithetically to its linear transcript counterpart, which acts as a tumor suppressor by encoding the Pokemon transcription factor. We find that circPOK regulates pro-proliferative and pro-angiogenic factors by co-activation of the ILF2/3 complex. Importantly, the expression of Pokemon protein and circRNA is aberrantly uncoupled in cancer through differential post-transcriptional regulation. Thus, we identify a novel type of genetic unit, the iRegulon, that yields biochemically distinct RNA products, circular and linear, with diverse and antithetical functions. Our findings further expand the cellular repertoire towards the control of normal biological outputs, while aberrant expression of such components may underlie disease pathogenesis including cancer.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31209250      PMCID: PMC6796857          DOI: 10.1038/s41422-019-0192-1

Source DB:  PubMed          Journal:  Cell Res        ISSN: 1001-0602            Impact factor:   25.617


  49 in total

1.  Circular RNA-encoded oncogenic E-cadherin variant promotes glioblastoma tumorigenicity through activation of EGFR-STAT3 signalling.

Authors:  Xinya Gao; Xin Xia; Fanying Li; Maolei Zhang; Huangkai Zhou; Xujia Wu; Jian Zhong; Zheng Zhao; Kun Zhao; Dawei Liu; Feizhe Xiao; Qiang Xu; Tao Jiang; Bo Li; Shi-Yuan Cheng; Nu Zhang
Journal:  Nat Cell Biol       Date:  2021-03-04       Impact factor: 28.824

Review 2.  The expanding regulatory mechanisms and cellular functions of circular RNAs.

Authors:  Ling-Ling Chen
Journal:  Nat Rev Mol Cell Biol       Date:  2020-05-04       Impact factor: 94.444

Review 3.  The emerging roles of circRNAs in cancer and oncology.

Authors:  Lasse S Kristensen; Theresa Jakobsen; Henrik Hager; Jørgen Kjems
Journal:  Nat Rev Clin Oncol       Date:  2021-12-15       Impact factor: 66.675

4.  Characterization of Circular RNAs.

Authors:  Yang Zhang; Li Yang; Ling-Ling Chen
Journal:  Methods Mol Biol       Date:  2021

Review 5.  Biogenesis and Functions of Circular RNAs Come into Focus.

Authors:  Mei-Sheng Xiao; Yuxi Ai; Jeremy E Wilusz
Journal:  Trends Cell Biol       Date:  2020-01-20       Impact factor: 20.808

6.  [Circular RNA expression pattern and competing endogenous RNA network involved in rotator cuff tendinopathy].

Authors:  Zilu Ge; Binghua Zhou; Xiaolong Zheng; Mingyu Yang; Jingtong Lü; Honghao Deng; Kanglai Tang; Wan Chen
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2020-05-15

Review 7.  Fast and furious: insights of back splicing regulation during nascent RNA synthesis.

Authors:  Wei Xue; Xu-Kai Ma; Li Yang
Journal:  Sci China Life Sci       Date:  2021-02-09       Impact factor: 6.038

Review 8.  RNA in cancer.

Authors:  Gregory J Goodall; Vihandha O Wickramasinghe
Journal:  Nat Rev Cancer       Date:  2020-10-20       Impact factor: 60.716

Review 9.  Targeting circular RNAs as a therapeutic approach: current strategies and challenges.

Authors:  Alina T He; Jinglei Liu; Feiya Li; Burton B Yang
Journal:  Signal Transduct Target Ther       Date:  2021-05-21

10.  HNRNPL Circularizes ARHGAP35 to Produce an Oncogenic Protein.

Authors:  Yan Li; Bing Chen; Jingjing Zhao; Qin Li; Siyuan Chen; Tianan Guo; Yuchen Li; Hongyan Lai; Zhiao Chen; Zhiqiang Meng; Weijie Guo; Xianghuo He; Shenglin Huang
Journal:  Adv Sci (Weinh)       Date:  2021-05-01       Impact factor: 16.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.